| Members |
targetComponentId |
| Rupture of uterus during and after labor - delivered |
Rupture of uterus after labor (disorder) |
| Rupture of uterus during and after labor NOS |
Rupture of uterus after labor (disorder) |
| Rupture of uterus during and after labor NOS |
Rupture of uterus during labor |
| Rupture of uterus during and after labor unspecified |
Rupture of uterus during labor |
| Rupture of uterus during and after labor unspecified |
Rupture of uterus after labor (disorder) |
| Rupture tendon leg or foot |
Rupture of tendon of lower limb |
| Ruptured cyst |
Ruptured cyst |
| Ruptured cyst |
Ruptured simple cyst (morphologic abnormality) |
| Ruptured membranes |
Spontaneous rupture of membranes (finding) |
| Ruptured sebaceous cyst |
Ruptured sebaceous cyst (morphologic abnormality) |
| Ruptured sebaceous cyst |
Ruptured trichilemmal cyst (morphologic abnormality) |
| Ruptured structure of left ovary |
Rupture of ovary (disorder) |
| Ruptured structure of right ovary |
Rupture of ovary (disorder) |
| Ruptured tubal pregnancy |
Miscarriage of tubal ectopic pregnancy |
| Ruptured tubal pregnancy |
Ruptured tubal pregnancy |
| Russian thistle pollen allergen |
Russian thistle pollen |
| Rye grass pollen allergen |
Rye grass pollen |
| SF-Sicilian virus |
Sandfly fever Sicilian virus (organism) |
| SF-Sicilian virus |
Sandfly fever Naples virus |
| STAR profile |
Social training achievement record (assessment scale) |
| STMV virus |
Bovine polyomavirus (organism) |
| Saccharides measurement |
Carbohydrate measurement |
| Saccharopolyspora species |
Saccharopolyspora |
| Saccharothrix species |
Saccharothrix |
| Sacral &/or coccyx sprain |
Sacrum sprain |
| Sacral &/or coccyx sprain |
Sprain of sacrococcygeal ligament |
| Sacral &/or coccyx sprain |
Sacrum sprain |
| Sacrococcygeal region of spine structure |
Structure of sacrococcygeal junction of vertebral column (body structure) |
| Sacrococcygeal spine |
Structure of sacrococcygeal junction of vertebral column (body structure) |
| Sacrococcygeal vertebrae |
Bone structure of vertebra of sacrococcygeal junction |
| Sacrococcygeal vertebrae |
Entire bone of vertebra of sacrococcygeal junction |
| Sacroiliac joint stability finding |
Sacroiliac instability |
| Saddle nose |
Saddle nose (disorder) |
| Saddle nose |
Congenital saddle nose (disorder) |
| Saddleback bird |
Philesturnus carunculatus (organism) |
| Saddleback bird |
Genus Philesturnus (organism) |
| Safety razor, reusable |
Safety razor (physical object) |
| Safety razor, single-use |
Safety razor (physical object) |
| Sage grouse |
Centrocercus urophasianus (organism) |
| Sage grouse |
Genus Centrocercus (organism) |
| Salbutamol 100micrograms CFC-free inhaler |
Albuterol (as albuterol sulfate) 100 microgram/actuation pressurized suspension for inhalation |
| Salbutamol 100micrograms breath-actuated aerosol inhaler |
Salbutamol (as salbutamol sulfate) 100 microgram/actuation powder for inhalation |
| Salbutamol 2mg/5mL sugar free syrup |
Salbutamol (as salbutamol sulfate) 400 microgram/mL oral solution |
| Salbutamol 4mg m/r capsule |
Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule |
| Salbutamol 4mg m/r tablet |
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Salbutamol 4mg m/r tablet |
Product containing precisely salbutamol (as salbutamol sulfate) 4 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Salbutamol 500micrograms/1mL injection |
Salbutamol (as salbutamol sulfate) 500 microgram/mL solution for injection |
| Salbutamol 8mg m/r capsule |
Product containing precisely salbutamol (as salbutamol sulfate) 8 milligram/1 each prolonged-release oral capsule (clinical drug) |
| Salbutamol 8mg m/r tablet |
Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet |
| Salbutamol 95micrograms breath-actuated dry powder inhaler |
Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation |
| Salcatonin 100iu/mL injection solution 1mL ampule |
Product containing precisely salmon calcitonin 100 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Salcatonin 200iu/mL injection solution 2mL vial |
Salmon calcitonin 200 unit/mL solution for injection |
| Salcatonin 50iu/mL injection solution 1mL ampule |
Product containing precisely salmon calcitonin 50 unit/1 milliliter conventional release solution for injection (clinical drug) |
| Salicylate level (& serum) |
Serum salicylate measurement |
| Salicylate level (& serum) |
Serum salicylate measurement |
| Salicylate level abnormal |
Salicylate above therapeutic range |
| Salicylate level abnormal |
Salicylate below therapeutic range |
| Salicylate level abnormal |
Salicylate above therapeutic range |
| Salicylate level abnormal |
Salicylate below therapeutic range |
| Salicylate level: [serum] or [blood] |
Salicylate blood measurement |
| Salicylate level: [serum] or [blood] |
Serum salicylate measurement |
| Salicylate prophylaxis &/or aspirin IHD |
Administration of prophylactic salicylate (procedure) |
| Salicylate prophylaxis &/or aspirin IHD |
Administration of prophylactic aspirin for ischemic heart disease (procedure) |
| Salicylate prophylaxis &/or aspirin IHD |
Administration of prophylactic aspirin for ischemic heart disease (procedure) |
| Salicylate prophylaxis &/or aspirin IHD |
Administration of prophylactic salicylate (procedure) |
| Salicylic acid in white soft paraffin 60%/40% ointment |
Product containing precisely salicylic acid 600 milligram/1 gram and white petrolatum 400 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
| Salicylic acid+zinc oxide 5%/20% dusting powder |
Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) |
| Salinivibrio species |
Salinivibrio |
| Salivary apparatus (& [duct] or [gland]) |
Entire salivary duct |
| Salivary apparatus (& [duct] or [gland]) |
Entire salivary gland |
| Salivary apparatus operation (& gland) |
Operation on salivary gland |
| Salivary apparatus operation (& gland) |
Salivary apparatus operation |
| Salivary gland dilator, reusable |
Salivary gland dilator |
| Salivary gland dilator, single-use |
Salivary gland dilator |
| Salivary gland imaging |
Salivary gland imaging procedure (procedure) |
| Salivary gland imaging |
Radionuclide salivary gland imaging procedure (procedure) |
| Salivary gland implantation |
Implantation procedure (procedure) |
| Salivary hyposecretion |
Xerostomia |
| Salivary hyposecretion |
Hyposecretion of salivary gland |
| Salivary operation (& parotid) |
Salivary apparatus operation |
| Salivary operation (& parotid) |
Operation on parotid gland |
| Salmeterol 25mcg inhaler |
Salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
| Salmeterol 50micrograms breath-actuated dry powder inhaler |
Salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
| Salmeterol+fluticasone propionate 25micrograms/125micrograms CFC-free inhaler |
Fluticasone propionate 125 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
| Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
| Salmeterol+fluticasone propionate 25micrograms/50micrograms CFC-free inhaler |
Fluticasone propionate 50 microgram and salmeterol (as salmeterol xinafoate) 25 microgram/actuation pressurized suspension for inhalation |
| Salmeterol+fluticasone propionate 50micrograms/100micrograms breath-actuated dry powder inhaler |
Fluticasone propionate 100 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
| Salmeterol+fluticasone propionate 50micrograms/250micrograms breath-actuated dry powder inhaler |
Fluticasone propionate 250 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
| Salmeterol+fluticasone propionate 50micrograms/500micrograms breath-actuated dry powder inhaler |
Fluticasone propionate 500 microgram and salmeterol (as salmeterol xinafoate) 50 microgram/actuation powder for inhalation |
| Salmonella 16;g,t;z42 |
Salmonella II 16:g,t:1,5 (organism) |
| Salmonella 16;g,t;z42 |
Salmonella II 16:m,t:[z42] |
| Salmonella 21:c:e,n,x |
Salmonella Rhone (organism) |
| Salmonella 21:c:e,n,x |
Salmonella II 21:c:e,n,x (organism) |
| Salmonella 21:z4,z24:- |
Salmonella II 21:z4,z24:- (organism) |
| Salmonella 21:z4,z24:- |
Salmonella IIIa 21:z4,z24:- (organism) |
| Salmonella 44:z4,z23:-- |
Salmonella II 44:z4,z23:- (organism) |
| Salmonella 44:z4,z23:-- |
Salmonella IV 44:z4,z23:- (organism) |
| Salmonella 44:z4,z23:-- |
Salmonella IV 44:z4,z23:- (organism) |
| Salmonella 44:z4,z23:-- |
Salmonella II 44:z4,z23:- (organism) |
| Salmonella 44:z4,z23:-- |
Salmonella IIIa 44:z4,z23:- (organism) |
| Salmonella 44:z4,z23:-- |
Salmonella IIIa 44:z4,z23:- (organism) |
FHIR